top of page
The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) October 11–14, 2026 

Organizing Committee

Denver_CO_2026OTS_ALC_D1B_edited.jpg

Annemieke Aartsma-Rus, Ph.D.

Leiden University Medical Center

6def66ac-0af2-48b1-a188-1bfd178cbac5

Julia Alterman, Ph.D.

UMass Chan Medical School

970ca722-9faa-41de-af06-9f830da1c7fe

Philippe Barthelemy, Ph.D.

Inserm

17fcf090-56f4-4620-94aa-c999f66d679c

Ilaria Brentari, Ph.D.

University of Trento

01d7f842-4caa-4dc8-bbbe-17b81a190d8c

David Butler, Ph.D.

Advisor

fe8de551-662b-4986-8fc2-453ecfdee29c

Hassan H. Fakih, Ph.D.

UMass Chan Medical School/RNA Therapeutics Institute

92506a34-7448-4d51-ac92-5731d6c098e1

Chantal Ferguson, MD, Ph.D.

Mass General Hospital

529dc974-d8c2-47af-bd8f-a636d37050f7

Alejandro (Alex) Garanto, Ph.D.

Radboud Univ. Medical Center

f0c24c0f-0118-42b9-8543-b0e8f593fbcc

Aurelie Goyenvalle, Ph.D.

University of Versailles

e526ba5f-b462-4319-bb31-8b8d9e64bc94

Scott Henry, Ph.D.

Ionis Pharmaceuticals

0aabe49a-39cf-4c39-bf4c-e775c3875f1c

Beatriz Ilamusi, Ph.D.

ARTHEx Biotech

c521d7fd-4ba1-4b34-bed9-de3092cda55b

Guillaume Jacquot, Ph.D.

VECT-HORUS

feb97283-59b2-4e27-a464-ccd64798ac6f

Maja Janas De Angelis, Ph.D., DABT

Alnylam Pharmaceuticals

cf6f8a75-f078-4f92-a242-57d0645008d4

Anastasia Khvorova, Ph.D.

RNA Therapeutic Institute/UMass Chan Medical School

addd2864-2b95-4abb-b11f-4874e14972c3

Daniel Knight, Ph.D. Candidate

Carleton University

4cb616f7-f8a7-4c94-b9c3-731cbbb75e59

Marc Lemaitre, Ph.D.

ML Consult

ff453d3d-b5cf-41f4-978e-7f3b568252ee

Laura Sepp, Ph.D.

GNMmeds LLC

f02eeab3-65bb-4552-a467-b2eb9476d61a

Helene Tran, Ph.D.

Servier Resarch & Development Institute

559acf3d-883b-453f-82f3-2152c58b2e1f

Jonathan Watts, Ph.D.

UMass Chan Medical School

9f1d43f1-d42c-42d8-b89e-698578a48fcd

Ken Yamada, Ph.D.

UMass Chan Medical School

7e813234-1663-47f9-b02f-b71ec695cd7c

Husam Younis, Ph.D.

Atrium Therapeutics

87286688-df41-4b13-ab8f-41b48e88ca83
bottom of page